E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/22/2017 in the Prospect News Investment Grade Daily.

New Issue: Medtronic details $2 billion sale of notes in three tranches

By Devika Patel

Knoxville, Tenn., March 22 – Medtronic plc offered further details about a $2 billion sale of senior notes (A3/A) that priced in three fixed-rate tranches on Tuesday, according to an FWP filed with the Securities and Exchange Commission.

The offering included two tranches of fixed-rate notes placed by Medtronic Global Holdings SCA and guaranteed by Medtronic plc and Medtronic, Inc.

Medtronic Global Holdings priced $1 billion of 1.7% two-year notes at a spread of Treasuries plus 47 basis points. These notes priced at 99.926 to yield 1.738%.

The company sold $850 million of 3.35% 10-year notes at 92 bps over Treasuries. These notes priced at par.

Also, subsidiary Medtronic, Inc. priced a $150 million add-on to the company’s 4.625% bonds due March 15, 2045 on Tuesday at a spread of Treasuries plus 117 bps. These notes priced at 106.542 to yield 4.224%.

The company originally sold $4 billion of the bonds on Dec. 1, 2014 at 99.732 to yield 4.642%, or 170 bps over Treasuries. The total outstanding now is $4.15 billion.

The reopened bonds are guaranteed by Medtronic plc and Medtronic Global Holdings SCA.

All three tranches priced on the tight side of guidance.

Citigroup Global Markets Inc., Goldman Sachs & Co. and Morgan Stanley & Co. LLC were the bookrunners.

Proceeds from the offering will be used for general corporate purposes.

Medtronic is a medical technology and services company based in Dublin. Subsidiary Medtronic Global Holdings is based in Luxembourg. Medtronic Inc. is based in Minneapolis.

Issuer:Medtronic plc
Amount:$2 billion
Description:Senior notes
Bookrunners:Citigroup Global Markets Inc., Goldman Sachs & Co. and Morgan Stanley & Co. LLC
Co-managers:BNP Paribas Securities Corp., Deutsche Bank Securities Inc., HSBC Securities (USA) Inc. and Mizuho Securities USA Inc.
Trade date:March 21
Settlement date:March 28
Ratings:Moody’s: A3
S&P: A
Distribution:SEC registered
Two-year notes
Issuing entity:Medtronic Global Holdings SCA
Guarantors:Medtronic plc and Medtronic, Inc.
Amount:$1 billion
Maturity:March 28, 2019
Coupon:1.7%
Price:99.926
Yield:1.738%
Spread:Treasuries plus 47 bps
Price guidance:Treasuries plus 50 bps area, plus or minus 3 bps
Call feature:Make-whole call at Treasuries plus 10 bps until March 28, 2019, then a par call
10-year notes
Issuing entity:Medtronic Global Holdings SCA
Guarantors:Medtronic plc and Medtronic, Inc.
Amount:$850 million
Maturity:April 1, 2027
Coupon:3.35%
Price:Par
Yield:3.35%
Spread:Treasuries plus 92 bps
Price guidance:Treasuries plus 95 bps area, plus or minus 3 bps
Call feature:Make-whole call at Treasuries plus 15 bps until Jan. 1, 2027, then a par call
Add-on to notes due 2045
Issuing entity:Medtronic, Inc.
Guarantors:Medtronic plc and Medtronic Global Holdings SCA
Amount:$150 million reopening
Maturity:March 15, 2045
Coupon:4.625%
Price:106.542
Yield:4.224%
Spread:Treasuries plus 117 bps
Call features:Make-whole call at Treasuries plus 30 bps until March 15, 2045, thereafter at par
Price guidance:Treasuries plus 120 bps area, plus or minus 3 bps
Total outstanding:$4.15 billion, including $4 billion priced on Dec. 1, 2014 to yield 170 bps over Treasuries

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.